Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.97
+0.07240.26%
Post-market: 27.90-0.0673-0.24%16:10 EDT
Volume:226
Turnover:6K
Market Cap:1.40M
PE:- -
High:27.97
Open:27.90
Low:27.90
Close:27.89
52wk High:29.89
52wk Low:24.32
Shares:50.00K
Float Shares:50.00K
Volume Ratio:2.06
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Estee Lauder enters global partnership with Profound

TIPRANKS
·
Sep 15

Estée Lauder Partners with Profound to Track and Boost Brand Visibility on Generative AI Platforms

Reuters
·
Sep 15

The EstÉE Lauder Companies Announces Partnership with Profound to Expand AI Visibility Across Its Global Brand Portfolio

THOMSON REUTERS
·
Sep 15

EU Antitrust Regulators to Inform Kimberly-Clark This Week About Competition Concerns About Deal, Sources Say

THOMSON REUTERS
·
Sep 14

Exclusive-Kimberly-Clark May Offer Concessions During EU Regulators' Preliminary Review in Bid to Secure Early Approval, Sources Say

THOMSON REUTERS
·
Sep 14

CITIC Securities Maintains "Outperform" Rating on Medical Aesthetics Sector, Citing Momentum in Leading Steady-Growth Companies

Stock News
·
Sep 12

AbbVie Announces Q4 2026 Dividend of R$ 0.37 Per Unit, Payable Nov. 23

Reuters
·
Sep 12

Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link

Reuters
·
Sep 12

AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV

TIPRANKS
·
Sep 12

Hims & Hers Health Price Target Announced at $32.00/Share by JP Morgan

Dow Jones
·
Sep 11

Deutsche sees Estee shares topping $120 by year-end in ‘bull case’

TIPRANKS
·
Sep 11

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

TIPRANKS
·
Sep 11

Align Technology Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 11

Estée Lauder Director Charlene Barshefsky Disposes of 3,775 Common Shares Worth $372,046.5

Reuters
·
Sep 11

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 11

AbbVie Declares Quarterly Cash Dividend of $1.73 a Share

Reuters
·
Sep 11

Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share

THOMSON REUTERS
·
Sep 11

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

TIPRANKS
·
Sep 11

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live
·
Sep 10

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

TIPRANKS
·
Sep 10